Identification of potent biparatopic antibodies targeting FGFR2 fusion driven cholangiocarcinoma.
Chaturantabut S, Oliver S, Frederick DT, Kim J, Robinson FP, Sinopoli A, Song TY, Rodriguez DJ, Chang L, Kesar D, He Y, Ching M, Dzvurumi R, Atari A, Tseng YY, Bardeesy N, Sellers WR.
Chaturantabut S, et al. Among authors: oliver s.
bioRxiv [Preprint]. 2024 Sep 18:2024.09.16.613045. doi: 10.1101/2024.09.16.613045.
bioRxiv. 2024.
PMID: 39345400
Free PMC article.
Preprint.